Argenx Se ARGX
NASDAQ ARGX
$962.22 +16.40 (+1.73%)
At close: Sep 24, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Revenue (2016 - 2026)

Argenx Se's (ARGX) quarterly Revenue came in at $1.5 billion in Q2 2026, up 59.71% on a YoY basis from $948.6 million in Q2 2025, and up 16.72% quarter-over-quarter from $1.3 billion in Q1 2026.

Analysis

Argenx Se (ARGX) Revenue (2016 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Revenue for 11 consecutive years, with $1.5 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Revenue rose 59.71% year-over-year to $1.5 billion; the trailing twelve-month figure through Jun 2026 stood at $5.2 billion (up 71.41% YoY), and the FY2025 full-year result was $4.2 billion, up 89.91% from the prior year.
  • Revenue grew to $1.5 billion in Q2 2026 per ARGX's latest filing, from $1.3 billion in the prior quarter.
  • Across five years, Revenue topped out at $1.5 billion in Q2 2026 and bottomed at $21.2 million in Q1 2022.
  • Historically, Revenue has averaged $596.8 million across 5 years, with a median of $438.0 million in 2024.
  • The widest YoY moves for Revenue: up 15224.27% in 2022, down 86.62% in 2022.
  • Over 5 years, Revenue stood at $173.4 million in 2022, then surged by 115.89% to $374.4 million in 2023, then jumped by 96.87% to $737.0 million in 2024, then surged by 74.46% to $1.3 billion in 2025, then grew by 17.83% to $1.5 billion in 2026.
  • According to Business Quant data, Revenue over the past three periods registered $1.5 billion, $1.3 billion, and $1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 25.31 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 16.99 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 15.38 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 7.80 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 3.33 Bn
10 Argenx Se 58.53 Bn 53.35 Bn 1.37 Bn 1.52 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.52 Bn
Mar 31, 2026 1.30 Bn
Dec 31, 2025 1.29 Bn
Sep 30, 2025 1.13 Bn
Jun 30, 2025 948.59 Mn
Mar 31, 2025 790.00 Mn
Dec 31, 2024 736.97 Mn
Sep 30, 2024 573.00 Mn
Jun 30, 2024 477.64 Mn
Mar 31, 2024 398.28 Mn
Dec 31, 2023 374.35 Mn
Sep 30, 2023 329.10 Mn
Jun 30, 2023 269.31 Mn
Mar 31, 2023 218.02 Mn
Dec 31, 2022 173.40 Mn
Sep 30, 2022 131.33 Mn
Jun 30, 2022 74.83 Mn
Mar 31, 2022 21.16 Mn
Dec 31, 2021 26.02 Mn
Sep 30, 2021 857,000.00
API Access

Argenx Se Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ARGX&period=max&api_key=YOUR_API_KEY